PRTC(PRTC)
PRTC
ANALYST COVERAGE2 analysts
BUY
▲ +227.6%upside to target
L $44.00
Med $57.00consensus
H $70.00Key MetricsTTM
Market Cap$423.58M
Revenue TTM$8.96M
Net Income TTM-$55.98M
Free Cash Flow-$219.20M
Gross Margin-471.2%
Operating Margin-2115.4%
Net Margin-2355.5%
Return on Equity-31.8%
Return on Assets-20.5%
Debt / Equity0.06
Current Ratio6.59
EPS TTM$-45.37
PRICE
Prev Close
17.42
Open
17.45
Day Range17.23 – 17.45
17.23
17.45
52W Range14.50 – 19.92
14.50
19.92
54% of range
VOLUME & SIZE
Avg Volume
8.9K
FUNDAMENTALS
P/E Ratio
-3.8x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
49
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 131 days
Sep 30
PRTC News
About
PureTech Health is a biotechnology company which develops medicines to combat serious diseases.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Daphne Zohar
Website
Spencer BallExecutive Vice President of Human Resources
Aleksandra FilipovicHead of Oncology
Allison Mead TalbotSenior Vice President of Communications & Head of Investor Relations
Robert LyneCEO & Director
Anita TerpstraSenior Vice President of Intellectual Property
Daphne ZoharFounder
Joy BauerChief Nutrition Officer
Lauren A. WhiteChief Financial Officer
David R. ElmalehCo-Founder & Senior Advisor
Eric ElenkoCo-Founder & President
Robert S. Langer Jr.Co-Founder & Non-Executive Director
Charles SherwoodGeneral Counsel & Company Secretary
Michael InbarChief Accounting Officer